Lisa Wilson
Investor Relations
Replay available
ANI Pharmaceuticals, Inc. (ANIP) Q1 2025 Earnings Call
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q1 2025 earnings conference call, held 2025-05-09. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Nikhil Lawani
President and Chief Executive Officer
Chris Mutz
Senior Vice President and Head of Rare Disease Business
Stephen Carey
Chief Financial Officer
Gary Nachman
Analyst, Raymond James
Faisal Khurshid
Analyst, Lyric Partners
Vamol Devan
Analyst, Guggenheim Securities
David Amsellem
Analyst, Piper Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Ani Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:03.216 And welcome to today's A&I Pharmaceuticals, Inc. 00:00:03.216 -- 00:00:06.902 first quarter 2025 earnings results call. 00:00:06.902 -- 00:00:09.566 Please note this call is being recorded. 00:00:09.566 -- 00:00:14.433 After the speaker's opening remarks, there will be a question and answer session. 00:00:14.433 -- 00:00:18.640 If you would like to ask a question during this time, simply press the star, then the 00:00:18.640 -- 00:00:21.805 number one on your telephone keypad. 00:00:21.805 -- 00:00:25.951 If you would like to withdraw your question, please press the star key, then number two 00:00:25.951 -- 00:00:31.264 on your telephone keypad. It is now my pleasure to turn the conference over to Lisa Wilson. 00:00:31.264 -- 00:00:33.264 Thank 00:00:34.527 -- 00:00:40.033 you, Operator. Welcome to A&I Pharmaceuticals Q1 2025 Earnings 00:00:40.033 -- 00:00:45.219 Results Call. This is Lisa Wilson, Investor Relations for A&I. 00:00:45.219 -- 00:00:50.605 With me on today's call are Nikhil Lawani, President and Chief Executive Officer, 00:00:50.605 -- 00:00:55.631 Stephen Carey, Chief Financial Officer, and Chris Mutz, Senior Vice President 00:00:55.631 -- 00:01:01.397 and Head of A&I's Rare Disease Business. You can also access the webcast of this call 00:01:01.397 -- 00:01:06.813 through the investor section of the ANI website at ANIFarmaceuticals.com. 00:01:07.649 -- 00:01:12.980 Before we get started, I would like to remind everyone that any statements made 00:01:12.980 -- 00:01:18.130 on today's conference call that express a belief, expectation, projection, 00:01:18.130 -- 00:01:23.280 forecast, anticipation, or intent regarding future events and the company's future 00:01:23.280 -- 00:01:28.751 performance may be considered fo...